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a b s t r a c t
A 45-year-old woman with dilated cardiomyopathy was admitted for the upgrade of a previously
implanted pacemaker. Echocardiography showed intraventricular dyssynchrony and a low ejection
fraction (0.35). Treatment with a cardiac resynchronization therapy deﬁbrillator (CRT-D) was selected
and the device was implanted. CRT-D interrogation revealed proper function. Following procedure
termination, the patient went into cardiac arrest and died despite resuscitation attempts. An autopsy
revealed that the medial aspect of the right atriumwas pierced by an active lead and that the aorta had a
deep lesion, 2 mm in length, on its lateral aspect. We explain the probable pathogenesis of this
patient's death.
& 2015 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
1. Introduction
Cardiac perforation is a dreaded complication of transvenous
pacemaker, cardiac resynchronization therapy deﬁbrillator (CRT-
D), and implantable cardioverter-deﬁbrillator (ICD) lead placement
because of the potential for critical morbidity and mortality.
2. Case report
We report the case of a 45-year-old woman affected by severe
dilated cardiomyopathy who was admitted to our Cardiology Depart-
ment for an upgrade of a previously implanted pacemaker. The patient
received a VVI pacemaker implant for complete atrioventricular block
22 years earlier and an upgrade (DDD mode) 11 years later. Echocar-
diography revealed intraventricular dyssynchrony and a low ejection
fraction (0.35). A CRT-D was selected for this patient and the device
was implanted.
The procedure was performed under local anesthesia. Leads were
inserted through the left subclavian vein: (a) an active ﬁxation double
catheter in the right ventricle, (b) a bipolar active ﬁxation lead in the
right auricle (Fig. 1), and (c) a bipolar lead introduced from the
coronary sinus into the antero-lateral vein.
The previously implanted pacemaker and one atrial lead were
removed (the old unipolar lead was left in the right ventricle) and a
CRT device was connected to the new implanted leads. The atrial lead
removal was uneventful. After satisfactory R-wave sensing (45mV)
and pacing thresholds (o1.0 V at 0.5-ms pulse width) had been
demonstrated, the patient underwent deﬁbrillation threshold testing
(DFT) to ensure proper device function. Sustained ventricular tachycar-
dia and ventricular ﬁbrillation were induced to make certain that the
device was able to constantly sense, detect, and terminate arrhythmias
with a shock at 25 J. During skin closure, the patient went into cardiac
arrest with pulseless electrical activity. Cardiopulmonary resuscitation
maneuvers were performed immediately and echocardiography
showed intrapericardial effusion that was partially drained. After 1 h,
pulseless electrical activity persisted, the patient was declared dead, and
resuscitation attempts were halted.
The unexpected fatal outcome resulted in an allegation of medical
negligence against the operating cardiologists. A board of physicians
consisting of a forensic doctor and a heart surgeon conducted a post-
mortem examination and analysis of the medical records.
At autopsy, approximately 180 cm3 of blood and clots were found
inside the pericardial cavity. Careful inspection of the aorta showed a
deep lesion, 2mm in length, on the antero-lateral aspect of the vessel
(Fig. 1) 2 cm above the valvular plane (Fig. 2). On the medial aspect of
the right atrium, the lead metal extremity was implanted at the base of
the auricle on the medial wall. The right atrium was very thin, with an
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average thickness of 2mm. Histology showed abundant adipose tissue
in its context, endocardial ﬁbrosis, and numerous foci of inﬂammatory
inﬁltration by various elements including lymphocytes and monocytes
as well numerous plasma cells and eosinophils, clearly indicating
myocarditis that was not recent.
The ascending aorta was incised and approximately 2 cm above
the noncoronary cusp, a pinpoint injury related to the lesion described
on the aortic adventia (Fig. 2) was noted.
3. Discussion
The pathogenetic mechanism underlying this patient's death can
be explained in the following manner: the active lead (Fig. 1),
positioned in the right atrium medial aspect, perforated the thin atrial
wall and the lateral aspect of the aortic wall. After aortic perforation,
the lead initially remained inside its wall, which explains why the
device interrogation revealed satisfactory R-wave sensing (45mV)
and pacing thresholds (o1.0 V at 0.5-ms pulse width). The patient
eventually underwent DFT to guarantee proper device function. At this
point, the active lead, positioned inside the aorta like a cork, slipped
out, causing cardiac tamponade. In a review of relevant literature, we
identiﬁed only ﬁve cases [1–5] of atrial damage by a pacemaker lead
with concomitant aortic wall perforation, as shown in Table 1. How-
ever, not all reports indicate whether the lead responsible for the
cardiac laceration was active or passive.
A board of physicians conducted a post-mortem examination
and their ﬁndings did not support a direct allegation of medical
Fig. 1. The explanted heart: a small hematoma is evident on the antero-lateral aspect of the aorta (white arrow); the medial aspect of the right atrium shows the lesion
where the lead metal extremity was implanted (black arrow).
Fig. 2. The aorta opened: a pinpoint injury was noted 2 cm above the noncoronary cusp (black arrow). This was related to the lesion described on the adventitial portion of
the aorta.
Table 1
Review of the literature: only ﬁve cases of atrial damage by a pacemaker lead with concomitant aortic wall perforation have been published.
Author Device Time after implant Symptoms Procedure Outcome
Kalijusto [1] P-M 14 days Chest pain Sternotomy Alive
Kashani [2] P-M active lead 1 day Pain, dyspnea Thorac/Sternot Alive
Sticco [3] P-M 14 days Syncope Thorac/Sternot Alive
deRoux [4] P-M active lead End procedure Hypotension Thoracotomy Dead
Di Marco [5] P-M active lead 6 h Ch. pain, hypot. Sternotomy Alive
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negligence against the operating cardiologists who performed the
ICD implant. The board analyzed the guidelines for cardiac pacing
and cardiac resynchronization therapy and considered the indica-
tions for the procedure performed on the patient to be correct. The
increased heart size shifted the right atrial appendage closer to the
adjacent lateral aspect of the aorta. At the same time, the
remarkable thinness of the right atrium was conducive to wall
perforation. The perforation was not necessarily a result of mal-
practice in electrode positioning, but was also caused by other
factors such as the pressure exerted during cardiac contraction.
Moreover, since she was bearing a pacemaker, the patient could
not undergo magnetic resonance imaging before the procedure to
highlight the thicknesses of the cardiac wall. In addition, her pre-
existing myocarditis undoubtedly reduced the chances of success-
ful resuscitation.
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